Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 17|pp. 7038–7051
The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer
Back to articleFigure 2(2 of 6)
100%
Figure 2
Figure 2.Kaplan-Meier platform showing the prognostic values of ALDH6A1, ALDH3A1 and SLC7A8 in GC. (A–I) The prognostic values of ALDH6A1, ALDH3A1 and SLC7A8 in GC patients. OS: overall survival, FP: first-progression, PPS: post progression survival.
Figure 2 — The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer | Aging